NASDAQ : VCRE
Vicore Pharma Holding AB (publ) — Financial statements
Healthcare · Biotechnology · Sweden
Last price 9.8 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 277.97M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Vicore Pharma Holding AB (publ) (VCRE) reported revenue of 3.99M SEK (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in SEK.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.99M | 3.82M | 109.35M | |||
| Gross Profit | 3.99M | 3.82M | 109.35M | |||
| Selling, General & Admin | 94.24M | 67.91M | 50.44M | 44.59M | 37.53M | 21.61M |
| Research & Development | 433.65M | 390.35M | 249.26M | 276.29M | 249.97M | 271.81M |
| Operating Expenses | 527.89M | 458.26M | 299.71M | 320.89M | 287.49M | 293.42M |
| Operating Income | -523.89M | -454.44M | -190.36M | -320.89M | -287.49M | -293.42M |
| Interest Expense | -60.00K | -8.00K | -2.00K | -8.00K | -11.00K | |
| Interest & Investment Income | 70.76M | 23.89M | 21.08M | 10.54M | 913.00K | 646.00K |
| Currency Exchange Gain (Loss) | -48.64M | -46.86M | 397.00K | -617.00K | -1.75M | -1.83M |
| EBT Excluding Unusual Items | -501.78M | -477.47M | -168.89M | -310.97M | -288.34M | -294.61M |
| Gain (Loss) on Sale of Investments | -356.00K | -468.00K | -2.12M | |||
| Pretax Income | -501.78M | -477.47M | -168.89M | -311.33M | -288.81M | -296.74M |
| Income Tax Expense | 259.00K | -256.00K | -384.00K | -384.00K | -254.00K | |
| Net Income | -502.04M | -477.47M | -168.63M | -310.94M | -288.42M | -296.48M |
| Net Income to Common | -502.04M | -477.47M | -168.63M | -310.94M | -288.42M | -296.48M |
| Shares Outstanding (Basic) | 263.36M | 239.88M | 136.84M | 96.56M | 72.21M | 69.68M |
| Shares Outstanding (Diluted) | 263.36M | 239.88M | 136.84M | 96.56M | 72.21M | 69.68M |
| EPS (Basic) | -1.91 | -1.99 | -1.23 | -3.22 | -3.99 | -4.25 |
| EPS (Diluted) | -1.91 | -1.99 | -1.23 | -3.22 | -3.99 | -4.25 |
| Free Cash Flow | -456.73M | -375.74M | -164.95M | -249.58M | -299.92M | -265.17M |
| Free Cash Flow Per Share | -1.73 | -1.57 | -1.21 | -2.58 | -4.15 | -3.81 |
| Gross Margin | 100.00% | 100.00% | 100.00% | |||
| Operating Margin | -13,116.97% | -11,905.82% | -174.09% | |||
| Profit Margin | -12,569.76% | -12,509.14% | -154.22% | |||
| Free Cash Flow Margin | -11,435.40% | -9,843.78% | -150.85% | |||
| EBITDA | -452.20M | -188.12M | -317.47M | -283.88M | -290.06M | |
| EBITDA Margin | -172.04% | |||||
| D&A For EBITDA | 2.24M | 2.24M | 3.42M | 3.61M | 3.36M | |
| EBIT | -523.89M | -454.44M | -190.36M | -320.89M | -287.49M | -293.42M |
| EBIT Margin | -174.09% |
Balance sheet
Fiscal year January - December; amounts in SEK.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 428.59M | 578.15M | 1.16B | 333.62M | 256.80M | 294.20M |
| Short-Term Investments | 477.05M | 588.59M | 149.15M | 4.94M | 77.28M | |
| Cash & Short-Term Investments | 905.64M | 1.17B | 1.16B | 482.77M | 261.74M | 371.48M |
| Other Receivables | 7.45M | 16.24M | 19.75M | 3.13M | 2.18M | 1.42M |
| Receivables | 7.45M | 16.24M | 19.75M | 3.13M | 2.18M | 1.42M |
| Prepaid Expenses | 13.01M | 33.94M | 19.82M | 9.70M | 5.87M | 5.03M |
| Total Current Assets | 926.10M | 1.22B | 1.20B | 495.60M | 269.79M | 377.93M |
| Property, Plant & Equipment | 25.00K | 117.00K | 401.00K | |||
| Long-Term Investments | 5.41M | |||||
| Other Intangible Assets | 2.22M | 68.10M | 67.43M | |||
| Other Long-Term Assets | 3.77M | 1.71M | ||||
| Total Assets | 929.87M | 1.22B | 1.20B | 497.84M | 338.01M | 451.17M |
| Accounts Payable | 20.01M | 39.47M | 29.97M | 17.92M | 23.50M | 23.98M |
| Accrued Expenses | 49.46M | 65.80M | 15.75M | 14.64M | 18.22M | 40.14M |
| Current Portion of Leases | 65.00K | |||||
| Current Income Taxes Payable | 61.00K | 1.93M | 1.13M | 760.00K | 335.00K | |
| Other Current Liabilities | 3.57M | 13.10M | 18.04M | 7.26M | 3.88M | 1.26M |
| Total Current Liabilities | 73.04M | 118.43M | 65.69M | 40.96M | 46.42M | 65.72M |
| Long-Term Leases | 320.00K | |||||
| Long-Term Deferred Tax Liabilities | 593.00K | 905.00K | 1.21M | |||
| Other Long-Term Liabilities | 3.20M | 4.74M | 556.00K | 898.00K | 1.60M | 600.00K |
| Total Liabilities | 76.25M | 123.17M | 66.25M | 42.45M | 48.92M | 67.85M |
| Common Stock | 140.76M | 140.76M | 117.29M | 55.86M | 40.92M | 35.88M |
| Additional Paid-In Capital | 2.88B | 2.45B | 1.67B | 1.21B | 1.02B | |
| Retained Earnings | -1.92B | -1.44B | -1.27B | -962.65M | -674.23M | |
| Comprehensive Income & Other | 712.86M | |||||
| Shareholders' Equity | 853.63M | 1.10B | 1.13B | 455.39M | 289.08M | 383.32M |
| Total Liabilities & Equity | 929.87M | 1.22B | 1.20B | 497.84M | 338.01M | 451.17M |
| Total Debt | 65.00K | 320.00K | ||||
| Net Cash (Debt) | 905.64M | 1.17B | 1.16B | 482.77M | 261.68M | 371.16M |
| Net Cash Per Share | 3.44 | 4.86 | 8.45 | 5.00 | 3.62 | 5.33 |
| Filing Date Shares Outstanding | 281.53M | 281.53M | 234.58M | 111.72M | 81.85M | 71.76M |
| Total Common Shares Outstanding | 281.53M | 281.53M | 234.58M | 111.72M | 81.85M | 71.76M |
| Working Capital | 853.06M | 1.10B | 1.13B | 454.64M | 223.37M | 312.21M |
| Book Value Per Share | 3.03 | 3.89 | 4.81 | 4.08 | 3.53 | 5.34 |
| Tangible Book Value | 853.63M | 1.10B | 1.13B | 453.17M | 220.98M | 315.89M |
| Tangible Book Value Per Share | 3.03 | 3.89 | 4.81 | 4.06 | 2.70 | 4.40 |
| Machinery | 147.00K | 147.00K | 147.00K |
Cash flow statement
Fiscal year January - December; amounts in SEK.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -502.04M | -477.47M | -168.63M | -310.94M | -288.42M | -296.48M |
| Depreciation & Amortization | 2.24M | 3.42M | 3.61M | 3.60M | ||
| Loss (Gain) From Sale of Assets | 2.00M | |||||
| Asset Writedown & Restructuring Costs | 62.55M | |||||
| Other Operating Activities | 18.65M | 60.93M | 3.28M | 6.03M | 3.83M | 639.00K |
| Change in Accounts Receivable | -16.75M | -3.08M | -35.60M | -4.28M | -1.60M | -340.00K |
| Change in Accounts Payable | 43.40M | 43.89M | 33.77M | -6.36M | -19.34M | 27.41M |
| Operating Cash Flow | -456.73M | -375.74M | -164.95M | -249.58M | -299.92M | -265.17M |
| Sale (Purchase) of Intangibles | -3.00M | |||||
| Investment in Securities | 100.77M | -600.51M | 149.04M | -144.46M | 77.00M | -7.00M |
| Investing Cash Flow | 100.12M | -600.51M | 149.04M | -144.46M | 74.00M | -7.00M |
| Issuance of Common Stock | 455.08M | 455.10M | 882.14M | 500.41M | 200.00M | 336.00M |
| Other Financing Activities | -24.55M | -24.55M | -48.08M | -29.55M | -12.96M | -17.82M |
| Financing Cash Flow | 430.53M | 430.54M | 834.06M | 470.86M | 187.04M | 318.18M |
| Foreign Exchange Rate Adjustments | 3.07M | -32.16M | 4.23M | 1.48M | -431.00K | |
| Net Cash Flow | 76.98M | -577.85M | 822.38M | 76.82M | -37.40M | 45.58M |
| Free Cash Flow | -456.73M | -375.74M | -164.95M | -249.58M | -299.92M | -265.17M |
| Free Cash Flow Margin | -11,435.40% | -9,843.78% | -150.85% | |||
| Free Cash Flow Per Share | -1.73 | -1.57 | -1.21 | -2.58 | -4.15 | -3.81 |
| Levered Free Cash Flow | -282.98M | -222.43M | -111.25M | -200.41M | -195.17M | -160.92M |
| Unlevered Free Cash Flow | -282.98M | -222.40M | -111.25M | -200.41M | -195.16M | -160.92M |
| Cash Interest Paid | 59.00K | 59.00K | 7.00K | 2.00K | 8.00K | 8.00K |
| Cash Income Tax Paid | 259.00K | |||||
| Change in Working Capital | 26.65M | 40.81M | -1.84M | -10.65M | -20.94M | 27.07M |
Ratios
Fiscal year January - December; amounts in SEK.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 277.97M | 345.14M | 179.10M | 157.53M | 140.55M | 110.47M |
| Enterprise Value | 185.78M | 254.46M | 144.73M | 102.69M | 124.28M | 61.09M |
| PS Ratio | 674.53 | 833.44 | 18.13 | |||
| PB Ratio | 3.16 | 2.90 | 1.75 | 3.48 | 5.07 | 2.61 |
| P/TBV Ratio | 3.16 | 2.90 | 1.75 | 3.50 | 6.63 | 3.16 |
| EV/Sales Ratio | 450.83 | 614.46 | 14.65 | |||
| Debt / Equity Ratio | 0.00 | 0.00 | ||||
| Net Debt / Equity Ratio | -1.06 | -1.06 | -1.02 | -1.06 | -0.91 | -0.97 |
| Net Debt / EBITDA Ratio | 2.58 | 6.14 | 1.52 | 0.92 | 1.28 | |
| Net Debt / FCF Ratio | 1.98 | 3.10 | 7.01 | 1.93 | 0.87 | 1.40 |
| Asset Turnover | 0.00 | 0.00 | 0.13 | |||
| Quick Ratio | 12.50 | 9.99 | 17.90 | 11.86 | 5.69 | 5.67 |
| Current Ratio | 12.68 | 10.28 | 18.20 | 12.10 | 5.81 | 5.75 |
| Return on Equity (ROE) | -56.99% | -42.92% | -21.28% | -83.53% | -85.79% | -80.37% |
| Return on Assets (ROA) | -34.35% | -23.53% | -14.05% | -47.99% | -45.54% | -42.76% |
| Return on Capital Employed (ROCE) | -61.10% | -41.30% | -16.80% | -70.20% | -98.60% | -76.10% |
| Earnings Yield | -19.85% | -15.01% | -8.51% | -19.63% | -19.69% | -29.68% |
| FCF Yield | -16.76% | -11.81% | -8.32% | -15.75% | -20.47% | -26.55% |
| Buyback Yield / Dilution | -32.83% | -75.30% | -41.72% | -33.71% | -3.64% | -28.44% |